Tolerance Induction Therapy

About ImmunoFree

ImmunoFree is a private, clinical-stage biotech targeting a paradigm shift in post-transplant care by using stem cell technology to induce immune tolerance, thereby freeing patients from lifelong immunosuppressive drugs. The company appears to be advancing its programs through clinical trials at major academic medical centers, as evidenced by patient testimonials and press coverage from institutions like Northwestern Medicine. With a prestigious Scientific Advisory Board and a focus on kidney transplantation, ImmunoFree is positioned to address a significant unmet need with potentially transformative clinical and economic benefits.

Therapeutic Areas

Other Kidney Transplant Rejection Prevention Drugs